Jounce Therapeutics Inc (JNCE)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2017 | 09-2017 | 06-2017 | 03-2017 | 12-2016 | |
| Sales | 12,989 | 18,077 | 20,289 | 20,289 | 20,289 |
| Gross Profit | 12,989 | 18,077 | 20,289 | 20,289 | 20,289 |
| Operating Expenses | 24,541 | 22,465 | 23,317 | 20,536 | 15,307 |
| Operating Income | -11,552 | -4,388 | -3,028 | -247 | 4,982 |
| Other Income | 703 | 721 | 752 | 632 | 484 |
| Pre-tax Income | -10,849 | -3,667 | -2,276 | 385 | 5,466 |
| Income Tax | -1,485 | 417 | 1,104 | N/A | N/A |
| Net Income Continuous | -9,364 | -4,084 | -3,380 | 385 | 5,466 |
| Net Income | $-9,364 | $-4,084 | $-3,380 | $385 | $5,466 |
| EPS Basic Total Ops | -0.31 | -0.13 | -0.11 | -0.02 | 2.97 |
| EPS Basic Continuous Ops | -0.33 | -0.13 | -0.11 | 0.02 | 3.51 |
| EPS Diluted Total Ops | -0.31 | -0.13 | -0.11 | -0.02 | 3.01 |
| EPS Diluted Continuous Ops | -0.33 | -0.13 | -0.11 | 0.02 | 4.56 |
| EBITDA(a) | $-10,324 | $-3,170 | $-1,125 | $998 | $5,764 |